{
  "actions": [
    {
      "acted_at": "2001-04-06", 
      "references": [
        {
          "reference": "CR S3760-3761", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-04-06", 
      "committee": "Committee on the Judiciary", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on the Judiciary.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2001-10-18", 
      "in_committee": "Committee on the Judiciary", 
      "references": [], 
      "status": "REPORTED", 
      "text": "Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.", 
      "type": "calendar"
    }, 
    {
      "acted_at": "2002-06-20", 
      "committee": "the Judiciary", 
      "references": [], 
      "text": "Committee on the Judiciary. Reported by Senator Leahy with an amendment in the nature of a substitute. With written report No. 107-167.", 
      "type": "reported"
    }, 
    {
      "acted_at": "2002-06-20", 
      "calendar": "Senate Legislative", 
      "number": "431", 
      "references": [], 
      "text": "Placed on Senate Legislative Calendar under General Orders. Calendar No. 431.", 
      "type": "calendar", 
      "under": "General Orders"
    }, 
    {
      "acted_at": "2002-11-18", 
      "references": [
        {
          "reference": "CR S11339-11342", 
          "type": "consideration"
        }, 
        {
          "reference": "CR S11339-11340", 
          "type": "text of measure as reported in Senate"
        }
      ], 
      "text": "Measure laid before Senate by unanimous consent.", 
      "type": "action"
    }, 
    {
      "acted_at": "2002-11-18", 
      "references": [], 
      "text": "The committee substitute as amended agreed to by Unanimous Consent.", 
      "type": "action"
    }, 
    {
      "acted_at": "2002-11-18", 
      "how": "by Unanimous Consent", 
      "references": [
        {
          "reference": "CR S11341-11342", 
          "type": "text"
        }
      ], 
      "result": "pass", 
      "status": "PASS_OVER:SENATE", 
      "text": "Passed Senate with an amendment by Unanimous Consent.", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "s"
    }, 
    {
      "acted_at": "2002-11-19", 
      "references": [], 
      "text": "Message on Senate action sent to the House.", 
      "type": "action"
    }, 
    {
      "acted_at": "2002-11-19T12:02:00-05:00", 
      "references": [], 
      "text": "Received in the House.", 
      "type": "action"
    }, 
    {
      "acted_at": "2002-11-19", 
      "committee": "Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2002-11-19", 
      "committee": "House Energy and Commerce", 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2002-11-19", 
      "committee": "House Judiciary", 
      "references": [], 
      "text": "Referred to House Judiciary", 
      "type": "referral"
    }, 
    {
      "acted_at": "2002-11-22", 
      "in_committee": "House Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [
    {
      "amendment_id": "s4965-107", 
      "amendment_type": "s", 
      "chamber": "s", 
      "number": "4965"
    }
  ], 
  "bill_id": "s754-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "markup", 
        "reporting"
      ], 
      "committee": "Senate Judiciary", 
      "committee_id": "SSJU"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Cantwell, Maria", 
      "sponsored_at": "2001-07-09", 
      "state": "WA", 
      "thomas_id": "00172", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Durbin, Richard", 
      "sponsored_at": "2001-04-06", 
      "state": "IL", 
      "thomas_id": "00326", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Feingold, Russell D.", 
      "sponsored_at": "2001-05-21", 
      "state": "WI", 
      "thomas_id": "01331", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Grassley, Chuck", 
      "sponsored_at": "2002-06-21", 
      "state": "IA", 
      "thomas_id": "00457", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Kohl, Herb", 
      "sponsored_at": "2001-04-06", 
      "state": "WI", 
      "thomas_id": "01380", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Schumer, Charles E.", 
      "sponsored_at": "2001-04-06", 
      "state": "NY", 
      "thomas_id": "01036", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "senate_passage_result": "pass", 
    "senate_passage_result_at": "2002-11-18", 
    "vetoed": false
  }, 
  "introduced_at": "2001-04-06", 
  "number": "754", 
  "official_title": "A bill to enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Drug Competition Act of 2002", 
  "sponsor": {
    "district": null, 
    "name": "Leahy, Patrick J.", 
    "state": "VT", 
    "thomas_id": "01383", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "PASS_OVER:SENATE", 
  "status_at": "2002-11-18", 
  "subjects": [
    "Actions and defenses", 
    "Administrative procedure", 
    "Antitrust law", 
    "Civil rights and liberties, minority issues", 
    "Commerce", 
    "Drug approvals", 
    "Drug industry", 
    "Federal Trade Commission", 
    "Fines (Penalties)", 
    "Freedom of information", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Independent regulatory commissions", 
    "Injunctions", 
    "Law", 
    "Marketing", 
    "Pharmaceutical research", 
    "Research and development", 
    "Restrictive trade practices", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Commerce", 
  "summary": {
    "as": "Passed Senate amended", 
    "date": "2002-11-18", 
    "text": "Drug Competition Act of 2002 - (Sec. 5) Requires a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, prior to the generic drug entering the market, regarding the manufacture, marketing, or sale of the brand name or the generic drug, or regarding the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug, to each file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed.(Sec. 7) Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding.(Sec. 8) Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Drug Competition Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "reported to senate", 
      "title": "Drug Competition Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "passed senate", 
      "title": "Drug Competition Act of 2002", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:46:53-05:00"
}